D. I. Gabrilovich and S. Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, vol.9, pp.162-174, 2009.

E. Peranzoni, S. Zilio, I. Marigo, L. Dolcetti, and P. Zanovello, Myeloidderived suppressor cell heterogeneity and subset definition, Curr Opin Immunol, vol.22, pp.238-244, 2010.

D. I. Gabrilovich, S. Ostrand-rosenberg, and V. Bronte, Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, vol.12, pp.253-268, 2012.

N. Dilek, R. Vuillefroy-de-silly, G. Blancho, and B. Vanhove, Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance, Front Immunol, vol.3, p.208, 2012.

J. C. Ochando and S. H. Chen, Myeloid-derived suppressor cells in transplantation and cancer, Immunol Res, vol.54, pp.275-285, 2012.

J. G. Cripps and J. D. Gorham, MDSC in autoimmunity. Int Immunopharmacol, vol.11, pp.789-793, 2011.

B. Yin, G. Ma, C. Y. Yen, Z. Zhou, and G. X. Wang, Myeloid-derived suppressor cells prevent type 1 diabetes in murine models, J Immunol, vol.185, pp.5828-5834, 2010.

C. Hu, W. Du, X. Zhang, F. S. Wong, and L. Wen, The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice, J Immunol, vol.188, pp.294-301, 2012.

W. Fujii, E. Ashihara, H. Hirai, H. Nagahara, and N. Kajitani, Myeloidderived suppressor cells play crucial roles in the regulation of mouse collageninduced arthritis, J Immunol, vol.191, pp.1073-1081, 2013.

L. A. Haile, R. Von-wasielewski, J. Gamrekelashvili, C. Kruger, and O. Bachmann, Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway, Gastroenterology, vol.135, pp.871-875, 2008.

V. Singh, U. Mueller, P. Freyschmidt-paul, and M. Zoller, Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells, Eur J Immunol, vol.41, pp.2871-2882, 2011.

A. Valaperti, R. R. Marty, G. Kania, D. Germano, and N. Mauermann, CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis, J Immunol, vol.180, pp.2686-2695, 2008.

S. P. Zehntner, C. Brickman, L. Bourbonniere, R. L. Caruso, and M. , Neutrophils that infiltrate the central nervous system regulate T cell responses, J Immunol, vol.174, pp.5124-5131, 2005.

B. Zhu, Y. Bando, X. S. Yang, K. Anderson, and A. C. , CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis, J Immunol, vol.179, pp.5228-5237, 2007.

M. Ioannou, T. Alissafi, I. Lazaridis, G. Deraos, and J. Matsoukas, Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease, J Immunol, vol.188, pp.1136-1146, 2012.

W. Zhang, S. Liang, J. Wu, and A. Horuzsko, Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts, Transplantation, vol.86, pp.1125-1134, 2008.

A. S. Dugast, T. Haudebourg, F. Coulon, M. Heslan, and F. Haspot, Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion, J Immunol, vol.180, pp.7898-7906, 2008.

V. De-wilde, N. Van-rompaey, M. Hill, J. F. Lebrun, and P. Lemaitre, Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1, Am J Transplant, vol.9, pp.2034-2047, 2009.

M. R. Garcia, L. Ledgerwood, Y. Yang, J. Xu, and G. Lal, Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice, J Clin Invest, vol.120, pp.2486-2496, 2010.

N. Dilek, N. Poirier, C. Usal, B. Martinet, and G. Blancho, Control of transplant tolerance and intragraft regulatory T cell localization by myeloidderived suppressor cells and CCL5, J Immunol, vol.188, pp.4209-4216, 2012.

T. Wu, C. Sun, Z. Chen, Y. Zhen, and J. Peng, Smad3-deficient CD11b(+ )Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway, J Immunol, vol.189, pp.4989-5000, 2012.

Y. Luan, E. Mosheir, M. C. Menon, D. Wilson, and C. Woytovich, Monocytic Myeloid-Derived Suppressor Cells Accumulate in Renal Transplant Patients and Mediate CD4(+) Foxp3(+) Treg Expansion, Am J Transplant, vol.13, pp.3123-3131, 2013.

M. Leslie, Immunology. Regulatory T cells get their chance to shine, Science, vol.332, pp.1020-1021, 2011.

D. Adeegbe, P. Serafini, V. Bronte, A. Zoso, and C. Ricordi, In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice, Cell Transplant, vol.20, pp.941-954, 2011.

H. R. Turnquist, Z. Zhao, B. R. Rosborough, Q. Liu, and A. Castellaneta, IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival, J Immunol, vol.187, pp.4598-4610, 2011.

S. Rossner, C. Voigtlander, C. Wiethe, J. Hanig, and C. Seifarth, Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro, Eur J Immunol, vol.35, pp.3533-3544, 2005.

Z. Zhou, D. L. French, G. Ma, S. Eisenstein, and Y. Chen, Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells, Stem Cells, vol.28, pp.620-632, 2010.

H. S. Chou, C. C. Hsieh, R. Charles, L. Wang, and T. Wagner, MyeloidDerived Suppressor Cells Protect Islet Transplants By B7-H1 Mediated Enhancement of T Regulatory Cells, Transplantation, 2011.

Q. Guan, S. Moreno, G. Qing, C. R. Weiss, and L. Lu, The role and potential therapeutic application of myeloid-derived suppressor cells in TNBSinduced colitis, J Leukoc Biol, vol.94, pp.803-811, 2013.

Y. Nefedova, M. Huang, S. Kusmartsev, R. Bhattacharya, and P. Cheng, Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer, J Immunol, vol.172, pp.464-474, 2004.

E. Eruslanov, I. Daurkin, J. Ortiz, J. Vieweg, and S. Kusmartsev, Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells, J Leukoc Biol, vol.88, pp.839-848, 2010.

I. Marigo, E. Bosio, S. Solito, C. Mesa, and A. Fernandez, Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor, Immunity, vol.32, pp.790-802, 2010.

M. G. Lechner, D. J. Liebertz, and A. L. Epstein, Characterization of cytokineinduced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells, J Immunol, vol.185, pp.2273-2284, 2010.

S. O. Harbers, A. Crocker, G. Catalano, D. 'agati, V. Jung et al., Antibodyenhanced cross-presentation of self antigen breaks T cell tolerance, J Clin Invest, vol.117, pp.1361-1369, 2007.

L. Colonna, G. Catalano, C. Chew, D. 'agati, V. Thomas et al., Therapeutic targeting of Syk in autoimmune diabetes, J Immunol, vol.185, pp.1532-1543, 2011.

N. Obermajer, R. Muthuswamy, J. Lesnock, R. P. Edwards, and P. Kalinski, Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells, Blood, vol.118, pp.5498-5505, 2011.

K. Tomihara, M. Guo, T. Shin, X. Sun, and S. M. Ludwig, Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+ )Gr-1(+) cells, J Immunol, vol.184, pp.6151-6160, 2010.

H. Yi, C. Guo, X. Yu, D. Zuo, and X. Y. Wang, Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis, J Immunol, vol.189, pp.4295-4304, 2012.

T. V. Brennan, Q. Tang, F. C. Liu, V. Hoang, and M. Bi, Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts, J Surg Res, vol.169, pp.69-75, 2011.

K. Schmidt, S. Zilio, J. C. Schmollinger, V. Bronte, and T. Blankenstein, Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer, Blood, vol.121, pp.1740-1748, 2013.

M. Sade-feldman, J. Kanterman, E. Ish-shalom, M. Elnekave, and E. Horwitz, Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation, Immunity, vol.38, pp.541-554, 2013.

E. Ribechini, V. Greifenberg, S. Sandwick, and M. B. Lutz, Subsets, expansion and activation of myeloid-derived suppressor cells, Med Microbiol Immunol, vol.199, pp.273-281, 2009.

S. L. Highfill, P. C. Rodriguez, Q. Zhou, C. A. Goetz, and B. H. Koehn, Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, Blood, vol.116, pp.5738-5747, 2010.

Q. Tang, J. A. Bluestone, and S. M. Kang, CD4(+)Foxp3(+) regulatory T cell therapy in transplantation, J Mol Cell Biol, vol.4, pp.11-21, 2011.

S. Nagaraj, J. I. Youn, and D. I. Gabrilovich, Reciprocal relationship between myeloid-derived suppressor cells and T cells, J Immunol, vol.191, pp.17-23, 2013.

P. Y. Pan, G. Ma, K. J. Weber, J. Ozao-choy, and G. Wang, Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer, Cancer Res, vol.70, pp.99-108, 2010.

S. M. Centuori, M. Trad, C. J. Lacasse, D. Alizadeh, and C. B. Larmonier, Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-betainduced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD252 FoxP32 T cells, J Leukoc Biol, vol.92, pp.987-997, 2012.

C. Kurts, W. R. Heath, F. R. Carbone, A. J. Miller, and J. F. , Constitutive class I-restricted exogenous presentation of self antigens in vivo, J Exp Med, vol.184, pp.923-930, 1996.

K. A. Hogquist, S. C. Jameson, W. R. Heath, J. L. Howard, and M. J. Bevan, T cell receptor antagonist peptides induce positive selection, Cell, vol.76, pp.17-27, 1994.